Evaluation of a Pilot Protocol for Detecting Infant Hyperopia.
Journal
Optometry and vision science : official publication of the American Academy of Optometry
ISSN: 1538-9235
Titre abrégé: Optom Vis Sci
Pays: United States
ID NLM: 8904931
Informations de publication
Date de publication:
01 05 2023
01 05 2023
Historique:
medline:
25
5
2023
pubmed:
24
3
2023
entrez:
23
3
2023
Statut:
ppublish
Résumé
Highly hyperopic children are at greater risk for developing conditions such as strabismus, amblyopia, and early literacy and reading problems. High hyperopia is a common finding in infants in a pediatric medical practice, and early detection can be done effectively in that setting with tropicamide autorefraction. This study aimed to evaluate the effectiveness of a pilot screening program to detect high hyperopia in 2-month-old infants in a pediatric medical practice in Columbus, Ohio. Cycloplegic refractive error (1% tropicamide) was measured by retinoscopy and autorefraction with the Welch Allyn SureSight (Welch Allyn/Hillrom, Skaneateles Falls, NY) in 473 infants (55.4% female) who were undergoing their 2-month well-baby visit at their pediatrician's medical practice. Cycloplegic retinoscopy (1% cyclopentolate) was repeated at a subsequent visit in 35 infants with ≥+5.00 D hyperopia in the most hyperopic meridian during the screening. Twenty-eight infants (5.9%) had high hyperopia (spherical equivalent, ≥+5.00 D), and 61 (12.9%) had high hyperopia (≥+5.00 D in at least one meridian of at least one eye) by retinoscopy with 1% tropicamide. The mean ± standard deviation spherical equivalent tropicamide cycloplegic refractive error measured with retinoscopy was +2.54 ± 1.54 D (range, -3.25 to +7.00 D) and with SureSight was +2.29 ± 1.64 D (range, -2.90 to +7.53 D). Retinoscopy done using 1% cyclopentolate was 0.44 ± 0.54 D more hyperopic in spherical equivalent than with 1% tropicamide ( P < .001). High hyperopia was a common finding in 2-month-old infants in a pediatric medical setting that could be detected effectively by cycloplegic autorefraction using tropicamide. Greater cooperation between pediatric primary vision and medical care could lead to effective vision screenings designed to detect high hyperopia in infants.
Identifiants
pubmed: 36951871
doi: 10.1097/OPX.0000000000002011
pii: 00006324-202305000-00003
doi:
Substances chimiques
Mydriatics
0
Cyclopentolate
I76F4SHP7J
Tropicamide
N0A3Z5XTC6
Banques de données
ClinicalTrials.gov
['NCT03669146']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
304-311Informations de copyright
Copyright © 2023 American Academy of Optometry.
Déclaration de conflit d'intérêts
Conflict of Interest Disclosure: AMM has no reported financial conflicts of interest. DOM is a consultant for Vyluma, Inc.
Références
Mutti DO, Mitchell GL, Jones LA, et al. Accommodation, Acuity, and Their Relationship to Emmetropization in Infants. Optom Vis Sci 2009;86:666–76.
Kleinstein RN, Jones LA, Hullett S, et al. Refractive Error and Ethnicity in Children. Arch Ophthalmol 2003;121:1141–7.
Laatikainen L, Erkkila H. Refractive Errors and Other Ocular Findings in School Children. Acta Ophthalmol 1980;58:129–36.
Anker S, Atkinson J, Braddick O, et al. Non-cycloplegic Refractive Screening Can Identify Infants Whose Visual Outcome at 4 Years Is Improved by Spectacle Correction. Strabismus 2004;12:227–45.
Cotter SA, Varma R, Tarczy-Hornoch K, et al. Risk Factors Associated with Childhood Strabismus: The Multi-Ethnic Pediatric Eye Disease and Baltimore Pediatric Eye Disease Studies. Ophthalmology 2011;118:2251–61.
Pascual M, Huang J, Maguire MG, et al. Risk Factors for Amblyopia in the Vision in Preschoolers Study. Ophthalmology 2014;121:622–9.e1.
Kulp MT, Ciner E, et alVIP-HIP Study Group. Uncorrected Hyperopia and Preschool Early Literacy: Results of the Vision in Preschoolers-hyperopia in Preschoolers (VIP-HIP) Study. Ophthalmology 2016;123:681–9.
Cotter SA. Management of Childhood Hyperopia: A Pediatric Optometrist's Perspective. Optom Vis Sci 2007;84:103–9.
Donahue SP. Prescribing Spectacles in Children: A Pediatric Ophthalmologist's Approach. Optom Vis Sci 2007;84:110–4.
Mayer DL, Hansen RM, Moore BD, et al. Cycloplegic Refractions in Healthy Children Aged 1 through 48 Months. Arch Ophthalmol 2001;119:1625–8.
Mutti DO, Mitchell GL, Jones LA, et al. Axial Growth and Changes in Lenticular and Corneal Power during Emmetropization in Infants. Invest Ophthalmol Vis Sci 2005;46:3074–80.
American Optometric Association (AOA). InfantSEE: Establishing a Lifetime of Healthy Eyes and Vision. Available at: https://www.infantsee.org/about-us?sso=y . Accessed March 7, 2023.
Loh AR, Chiang MF. Pediatric Vision Screening. Pediatr Rev 2018;39:225–34.
American Academy of Pediatrics (AAP). Preventive Care/Periodicity Schedule. Recommendations for Preventative Pediatric Health Care. Available at: https://www.aap.org/periodicityschedule . Accessed March 7, 2023.
Morgan IG, Iribarren R, Fotouhi A, et al. Cycloplegic Refraction Is the Gold Standard for Epidemiological Studies. Acta Ophthalmol 2015;93:581–5.
U.S. Preventive Services Task Force. Vision Screening for Children 1 to 5 Years of Age: US Preventive Services Task Force Recommendation Statement. Pediatrics 2011;127:340–6.
Miller JM, Lessin HR, et al; American Academy of Pediatrics Section on Ophthalmology. Instrument-based Pediatric Vision Screening Policy Statement. Pediatrics 2012;130:983–6.
Maguire MG, Ying GS, Ciner EB, et al. Detection of Significant Hyperopia in Preschool Children Using Two Automated Vision Screeners. Optom Vis Sci 2022;99:114–20.
Gaiser H, Moore B, Srinivasan G, et al. Detection of Amblyogenic Refractive Error Using the Spot Vision Screener in Children. Optom Vis Sci 2020;97:324–31.
Morrison AM, Mutti DO. Repeatability and Validity of Peripheral Refraction with Two Different Autorefractors. Optom Vis Sci 2020;97:429–39.
Gettes BC, Belmont O. Tropicamide: Comparative Cycloplegic Effects. Arch Ophthalmol 1961;66:336–40.
Hopkins GA, O'Connor Davies PH, Pearson RM. The Actions and Uses of Opthalmic Drugs. 3rd ed. Boston, MA: Butterworths; 1989.
Egashira SM, Kish LL, Twelker JD, et al. Comparison of Cyclopentolate versus Tropicamide Cycloplegia in Children. Optom Vis Sci 1993;70:1019–26.
Mutti DO, Zadnik K, Egashira S, et al. The Effect of Cycloplegia on Measurement of the Ocular Components. Invest Ophthalmol Vis Sci 1994;35:515–27.
Twelker JD, Mutti DO. Retinoscopy in Infants Using a Near Noncycloplegic Technique, Cycloplegia with Tropicamide 1%, and Cycloplegia with Cyclopentolate 1%. Optom Vis Sci 2001;78:215–22.
Mutti DO, Sinnott LT, Lynn Mitchell G, et al. Ocular Component Development during Infancy and Early Childhood. Optom Vis Sci 2018;95:976–85.
Pennie FC, Wood IC, Olsen C, et al. A Longitudinal Study of the Biometric and Refractive Changes in Full-term Infants during the First Year of Life. Vision Res 2001;41:2799–810.
Luyckx J. [Measurement of the Optic Components of the Eye of the Newborn by Ultrasonic Echography]. Arch Ophtalmol Rev Gen Ophtalmol 1966;26:159–70.
Satiani NG, Mutti DO. Screening for Hyperopia in Infants Using the PowerRefractor. Optom Vis Sci 2011;88:905–11.
Ingram RM, Gill LE, Lambert TW. Effect of Spectacles on Changes of Spherical Hypermetropia in Infants Who Did, and Did Not, Have Strabismus. Br J Ophthalmol 2000;84:324–6.
Multi-Ethnic Pediatric Eye Disease Study Group. Prevalence of Myopia and Hyperopia in 6- to 72-month-old African American and Hispanic Children: The Multi-Ethnic Pediatric Eye Disease Study. Ophthalmology 2010;117:140–7.e3.
Atkinson J, Braddick O, Nardini M, et al. Infant Hyperopia: Detection, Distribution, Changes and Correlates—Outcomes from the Cambridge Infant Screening Programs. Optom Vis Sci 2007;84:84–96.